Mibelle Group targets Asia expansion with acquisition of Gowoonsesang

By Amanda Lim contact

- Last updated on GMT

Mibelle Group targets Asia expansion with acquisition of Gowoonsesang
Swiss private label manufacturers Mibelle Group is targeting expansion in the Asian market following the acquisition of Gowoonsesang, the developer of popular Korean derma-cosmetic brand Dr. G.

Gowoonsesang sold a 51% stake in its skincare brand Dr.G to Mibelle Group, a subsidiary of Migros Group, Switzerland’s largest retail company.

Key to Asia

This acquisition represents another milestone in the Mibelle Group’s international growth strategy, said the company in a press release.

The Mibelle Group said that it was particularly interested in South Korea, as the country has a reputation of being a global pioneer as well as a leader in health and beauty.

In acquiring the beloved Korean skin care brand, the Mibelle Group has found itself a solid footing in the Asian cosmetics market.

While the Mibelle Group did not disclose the financial details of the deal, it did reveal that Gowoonsesang generated $28.8m in sales last year.

Founded by Dr Ahn Gun Young in 2000, Gowoonsesang is the world’s second-largest medical skincare firm. Aside from producing its best-selling skincare line, the company also runs aesthetic clinics and develops dermatological devices.

Its skin care line, Dr. G, made waves in South Korea before expanding to other parts of Asia including China and Hong Kong, where it is widely available through beauty retailer Sasa. Currently, Dr. G is exported to over 30 countries.

“The acquisition of Gowoonsesang secures the Mibelle Group’s access to Asian markets, innovative technologies and business models, as well as synergies with its own projects,” ​said CEO of the Mibelle Group, Luigi Pedrocchi in a press release.

"We are entering one of the most important international skin care markets,”​ he continued. “The Mibelle Group is also supporting the Migros Group’s health strategy with new competency in dermocosmetics”

The company added that it would be taking over Gowoonsesang’s entire staff, which consists of about 60 members.

Road into Europe

While opportunities are abundant in Asia, the Mibelle Group also has its sights set on distributing Dr. G in Europe and North America.

“With the brand Dr. G, the Mibelle Group is expanding its pan-Asian distribution network, which is also very attractive to customers in Europe and North America,”​ said the company.

The Mibelle Group is a full-service provider for the production of private label goods and the third largest in Europe. The group employs around 1,200 people and generates sales of €450m ($521m). The company is part of M-Industry, a network of manufacturers owned by the Migros Group.

Related topics: Business & Financial, East Asia, Skin Care

Related news

Show more

Related products

show more

Change the Game with Water-Soluble Salicylic Acid!

Change the Game with Water-Soluble Salicylic Acid!

Tagra Biotechnologies | 28-Oct-2019 | Product Presentation

Watch Tagra’s Water Soluble Salicylic Acid WS SA50TM how-to video to see how to make alcohol-free formulas, sensitive skin formulas, and many more! WS...

BODY'licious, when body becomes the new face!

BODY'licious, when body becomes the new face!

SEPPIC | 21-Oct-2019 | Technical / White Paper

Seppic presents its new body care formulas collection: BODY’licious. Consumers are getting more demanding in terms of body product sensoriality and functionality:...

Microbiome-friendly long lasting deo

Microbiome-friendly long lasting deo

Symrise | 11-Oct-2019 | Product Brochure

SymDeo® B125 is a patented and simple aliphatic alcohol. It supports especially long lasting protection against body odor. While deodorants alone are typically...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars